BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Arrowhead Conferences’ Drug Delivery 2007 to Take Place April 9th-11th 2007 in San Francisco
 

MINNEAPOLIS, MN, February 15, 2007 – Drug Delivery 2007 has been organized to provide a critical examination of the drug delivery industry as well as insight from key industry leaders concerning cutting edge drug delivery technology, structuring mutually beneficial deals and the drug delivery industry’s impact on the field of biotechnology.

This conference will also provide an integral forum for leaders of the drug delivery, biotech and pharmaceutical industries to share ideas, network with other delegates and advance understanding of new drug delivery technologies.

In addition, there will be a pre-conference workshop on Quantitative Deal Structure in Drug Delivery Partnerships. For more information about this workshop, CLICK HERE

Key Themes

  • A critical examination of key emerging technologies in injectable, inhalable, transdermal, ophthalmic, intranasal, nanotechnology and oral drug delivery
  • Patent and IP valuation
  • Formation of successful alliances
  • Transitioning from drug delivery to specialty pharma
  • Making the deal - structuring mutually beneficial licensing arrangements
  • Unlocking the door to delivery of macromolecules Investing in drug delivery - insights into acquring capital and advancing business models

Speakers at this Event Include:

  • Allen Downs, Sr. Exec Dir Licensing, Purdue Pharma
  • Dr. Charles Hardy - Biomedical Scientist, Biovaluation & Analysis, Inc
  • Dr. Igor Gonda - CEO, Aradigm
  • Dr. Edward Maggio - CEO, Aegis Therapeutics
  • Timothy Sullivan - CEO, Mystic Pharmaceuticals
  • Dr. Lynnor Stevenson - CEO, Alta Biomedical
  • Dr. Rajiv Khosla - VP Business Development Services - Biovail
  • Lewis Bender - Sr VP Business Development - Emisphere Technologies
  • Brian Gorin - Managing Principal - Analysis Group
  • Mr. Steven Damon - VP Business Development - Altea Therapeutics
  • Edward Tuttle - Managing Principal - Analysis Group
  • Dr. Alain Rolland - Sr VP Product Development - Vical Incorporated
  • Dr. Robert Lee, VP Pharmaceutical Development - Novavax
  • Anil Dasu, VP Medical Device Engineering - Anesiva
  • Samantha Miller, VP Business Development - Anesiva

For more infomation about this conference, please visit www.arrowheadpublishers.com/conferences/drugdelivery2007 or contact us at 612-929-5203 or sales@arrowheadpublishers.net

To enquire about sponsorship and/or exhibiting at this conference please contact marketing@arrowheadpublishers.com

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.